Professional Documents
Culture Documents
10 0.24 10 10
12 0.24 12 12
9
8.33
6
ferrous iron concentration (g/L)
4 3.79
3.29
2.94
3
1 0.73
0.49
0.24 0.24 0.24 0.24 0.24
0
0 2 4 6 8 10 12 14
9K + At. F Days
9K + At. F + DBT 400mg 9K + At. F + DBT 500mg
9K + At. F 9K + At. F + DBT 300mg
0 9.8 0 9.8
2 7.1 2 7.35
4 4.41 4 6.12
6 1.96 6 2.94
8 0.49 8 1.22
10 0.12 10 0.24
12 0.02 12 0.12
12
10
9.8
8
7.35
7.1
ferrous iron conc.
6 6.12
4.41
4
2.94
2 1.96
1.22
0.49
0.24
0.12 0.12
0 0.02
0 2 4 6 8 10 12 14
day
2. No of cells (number 10*6)of different
concentration of DBT (300mg,400mg&500mg)
in presence of Acidothiobaccilus ferroxidans
(At.f).
9K + At. F + DBT
9K + At. F(control) 9K + At. F + DBT 300mg 9K + At. F + DBT 400mg 500mg
day no. of cells day no. of cells day no. of cells day no. of cells
10 33.18 10 6.8 10 10
12 28.27 12 5.1 12 12
Chart Title
70
60
58.44
50
40
no of cells (10*6)
33.18
30 29.49
28.27
22.2
20.88 20.88
20
18.82
16.82 16.76
15.1
14.29
11.75
11.68
10
7.89
6.8
4.97 4.41 5.1
3.9 3.99
0
0 2 4 6 8 10 12 14
Days
9K + At. F 9K + At. F + DBT 300mg 9K + At. F + DBT 400mg 9K + At. F + DBT 500mg
3. TLC profiling for degradation of of DBT
(300mg,400mg&500mg) using Acidothiobaccilus
ferroxidans (At.f).
2HBP
DBT
DBT
2-HBP